StonvexLoading…
StonvexStonvexStonvexCore line items from CDE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.34B | $856.19M | $2.07B | $1.40B | $840.71M |
Operating Income | Not available | $349.17M | $707.01M | $379.35M | $202.26M |
Net Income | Not available | $246.76M | $585.87M | $370.90M | $70.73M |
EPS (Diluted) | $0.35 | $0.35 | $0.95 | $0.61 | $0.18 |
Total Assets | Not available | $15.26B | $4.70B | $4.51B | $4.15B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $843.17M | $553.60M | $266.34M | $111.65M |
Free Cash Flow OCF − CapEx | Not available | $266.76M | $665.72M | $352.45M | $163.78M |
Shares Outstanding | Not available | 1.03B | 642.09M | 642.21M | 642.70M |